The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Open accessAbstract
The efficacy of cancer drugs is often limited because only a small fraction of the administered dose accumulates in tumors. Here we report an injectable nanoparticle generator (iNPG) that overcomes multiple biological barriers to cancer drug delivery. The iNPG is a discoidal micrometer-sized particle that can be loaded with chemotherapeutics. We conjugate doxorubicin to poly(L-glutamic acid) by means of a pH-sensitive cleavable linker, and load the polymeric drug (pDox) into iNPG to assemble iNPG-pDox. Once released from iNPG, pDox spontaneously forms nanometer-sized particles in aqueous solution. Intravenously injected iNPG-pDox accumulates at tumors due to natural tropism and enhanced vascular dynamics and releases pDox nanoparticles that are internalized by tumor cells. Intracellularly, pDox nanoparticles are transported to the perinuclear region and cleaved into Dox, thereby avoiding excretion by drug efflux pumps. Compared to its individual components or current therapeutic formulations, iNPG-pDox shows enhanced efficacy in MDA-MB-231 and 4T1 mouse models of metastatic breast cancer, including functional cures in 40–50% of treated mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Self-citationMultidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Liedtke, C., Mazouni, C., Hess, K. R., André, F., Tordai, A., Mejia, J. A., Symmans, W. F., Gonzalez-Angulo, A. M., Hennessy, B., Green, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4147 · Cited by 2,892
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Self-citationBae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Self-citationThe relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency
Lesniak, A., Salvati, A., Santos-Martinez, M. J., Radomski, M. W., Dawson, K. A., & Åberg, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309812z · Cited by 852
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
Self-citationIntravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Self-citationHurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., & Welch, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3559 · Cited by 411
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Self-citationMoghimi, S. M., & Patel, H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00131-2 · Cited by 240
pH Homeostasis of Cellular Organelles
Demaurex, N. (2002) · Physiology · doi:10.1152/physiologyonline.2002.17.1.1 · Cited by 233
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents
Fojo, T., & Menefee, M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm172 · Cited by 217
Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice
Godin, B., Chiappini, C., Srinivasan, S., Alexander, J. F., Yokoi, K., Ferrari, M., Decuzzi, P., & Liu, X. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201200869 · Cited by 195
Self-citationvan de Ven, A. L., Kim, P., Haley, O., Fakhoury, J. R., Adriani, G., Schmulen, J., Moloney, P., Hussain, F., Ferrari, M., Liu, X., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.021 · Cited by 188
Self-citationWhat does physics have to do with cancer?
Michor, F., Liphardt, J., Ferrari, M., & Widom, J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3092 · Cited by 176
Self-citationLü, X., & Kang, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900108106 · Cited by 120
Cooperative, Nanoparticle‐Enabled Thermal Therapy of Breast Cancer
Shen, H., You, J., Zhang, G., Žiemys, A., Li, Q., Bai, L., Deng, X., Erm, D. R., Liu, X., Li, C., et al. (2011) · Advanced Healthcare Materials · doi:10.1002/adhm.201100005 · Cited by 96
Self-citationAlhareth, K., Vauthier, C., Gueutin, C., Ponchel, G., & Moussa, F. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.01.025 · Cited by 83
Verma, S., Dent, S. F., Chow, B. J. W., Rayson, D., & Safra, T. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.008 · Cited by 67
Padilla‐Parra, S., Matos, P. M., Kondo, N., Marin, M., Santos, N. C., & Melikyan, G. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211714109 · Cited by 61
McConnell, K. I., Rhudy, J. R., Yokoi, K., Gu, J., Mack, A. A., Suh, J., Francesca, S. L., Sakamoto, J. H., & Serda, R. E. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.020 · Cited by 22
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Metadata
- Authors
- Xu, R., Zhang, G., Mai, J., Deng, X., Segura-Ibarra, V., Wu, S., Shen, J., Liu, H., Hu, Z., Chen, L., Huang, Y., Koay, E., Huang, Y., Liu, J., Ensor, J. E., Blanco, E., Liu, X., Ferrari, M., & Shen, H.
- Venue
- Nature Biotechnology
- Published
- 2016-03-14
- Volume
- 34
- Issue
- 4
- Pages
- 414-418
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2298943387
- Cited by
- 280
- References
- 29
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.